BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20858903)

  • 1. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
    Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
    J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
    Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
    Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter.
    Gallo A; Lo Sterzo C; Mori M; Di Matteo A; Bertini I; Banci L; Brunori M; Federici L
    J Biol Chem; 2012 Aug; 287(32):26539-48. PubMed ID: 22707729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergic role of nucleophosmin three-helix bundle and a flanking unstructured tail in the interaction with G-quadruplex DNA.
    Arcovito A; Chiarella S; Della Longa S; Di Matteo A; Lo Sterzo C; Scaglione GL; Federici L
    J Biol Chem; 2014 Aug; 289(31):21230-41. PubMed ID: 24952945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
    Federici L; Falini B
    Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-quadruplex DNA recognition by nucleophosmin: new insights from protein dissection.
    Scognamiglio PL; Di Natale C; Leone M; Poletto M; Vitagliano L; Tell G; Marasco D
    Biochim Biophys Acta; 2014 Jun; 1840(6):2050-9. PubMed ID: 24576674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural consequences of nucleophosmin mutations in acute myeloid leukemia.
    Grummitt CG; Townsley FM; Johnson CM; Warren AJ; Bycroft M
    J Biol Chem; 2008 Aug; 283(34):23326-32. PubMed ID: 18511415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4.
    De Cola A; Pietrangelo L; Forlì F; Barcaroli D; Budani MC; Graziano V; Protasi F; Di Ilio C; De Laurenzi V; Federici L
    Cell Death Dis; 2014 Sep; 5(9):e1427. PubMed ID: 25255220
    [No Abstract]   [Full Text] [Related]  

  • 9. The folding pathway of a functionally competent C-terminal domain of nucleophosmin: protein stability and denatured state residual structure.
    Chiarella S; Federici L; Di Matteo A; Brunori M; Gianni S
    Biochem Biophys Res Commun; 2013 May; 435(1):64-8. PubMed ID: 23618861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of intermolecular G-quadruplexes by full length nucleophosmin. Effect of a leukaemia-associated mutation.
    Bañuelos S; Lectez B; Taneva SG; Ormaza G; Alonso-Mariño M; Calle X; Urbaneja MA
    FEBS Lett; 2013 Jul; 587(14):2254-9. PubMed ID: 23742937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance.
    Scaloni F; Gianni S; Federici L; Falini B; Brunori M
    FASEB J; 2009 Aug; 23(8):2360-5. PubMed ID: 19289604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
    Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
    ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mutual interactions in the chemical and thermal stability of nucleophosmin NPM1 domains.
    Marasco D; Ruggiero A; Vascotto C; Poletto M; Scognamiglio PL; Tell G; Vitagliano L
    Biochem Biophys Res Commun; 2013 Jan; 430(2):523-8. PubMed ID: 23232117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
    Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
    Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
    Du Pisani LA; Shires K
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
    Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
    FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions.
    Di Natale C; Scognamiglio PL; Cascella R; Cecchi C; Russo A; Leone M; Penco A; Relini A; Federici L; Di Matteo A; Chiti F; Vitagliano L; Marasco D
    FASEB J; 2015 Sep; 29(9):3689-701. PubMed ID: 25977257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleophosmin in Its Interaction with Ligands.
    Cela I; Di Matteo A; Federici L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
    La Manna S; Florio D; Di Natale C; Napolitano F; Malfitano AM; Netti PA; De Benedictis I; Marasco D
    Bioorg Chem; 2021 Aug; 113():104997. PubMed ID: 34044346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.